You are here: Industry Insights > Mologic

News List

Mologic’s COVID-19 Rapid Antigen Self-Test Selected by NIH for RADx Initiative Funding americanpharmaceuticalreview
April 09, 2021
Mologic announced its rapid antigen self-test for COVID-19 has been selected by the Rapid Acceleration of Diagnostics (RADxSM) initiative launched by the U.S. National Institutes of Health (NIH).
Mologic Receives CE Mark Approval for COVID-19 Rapid Antigen Test americanpharmaceuticalreview
December 31, 2020
Mologic has announced its professional-use COVID-19 Rapid Antigen Test has been certified with a CE mark, following independent assessment by the Liverpool School of Tropical Medicine (LSTM).
Mologic, Partners Begin Validation Process for COVID-19 Point-of-Need Diagnostic Test americanpharmaceuticalreview
March 27, 2020
Mologic has initiated early validation of COVID-19 point-of-need diagnostic tests with the Liverpool School of Tropical Medicine and St Georges’ University London.
Mologic Receives Financial Award to Develop Rapid Diagnostic Test for COVID-19 americanpharmaceuticalreview
March 09, 2020
Mologic has been awarded circa £1 million by the Wellcome Trust and the Department for International Development (DFID) ), as part of the UK government’s £46 million international coronavirus (COVID-19) prevention ...